Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

Official title

Etude de faisabilité d'un Parcours de Transition à la Sortie d'Hospitalisation complète en Oncologie - Etude Pilote Monocentrique

Overview

Patient reported outcomes (PRO) measure the health status directly reported by the patients, without external interpretation, generally collected using self-questionnaires, including online tools (ePRO). This approach is useful in early detection of signs of relapse, with reduced anxiety, improved quality of life and survival, and reduced readmissions to emergency departments in patients with advanced cancer. In the current context where hospitalization is increasingly short, the transition from hospital to home is a critical moment that poses a significant safety challenge Patient follow-up strategies help patients return home, particularly in surgery, with telephone calls from a nurse the day after or several days after discharge. In oncology, telephone calls from the pharmacist 3 days after discharge from hospital helped to identify undesirable effects of treatments. In general medicine, these calls have led to improved patient satisfaction, reduced use of emergency departments and the resolution of drug-related problems, but are costly. The introduction of post-hospitalization ePRO monitoring in oncology could ensure effective follow-up while keeping costs under control. A coordinating nurse could manage this process and play a crucial role in accompanying patients when they return home. The study authors aimed to evaluate the feasibility of a transitional nurse consultation and ePRO follow-up on discharge from full hospitalization in oncology in this population of frail and elderly patients.

Interventions

• Other OncoCare transition program
  Interview with the coordinating nurse who reviews the patient's prescriptions and appointments, installs the electronic patient-reported outcome (ePRO) application on the patient's smartphone and explains collection of any symptoms. ePRO symptom monitoring by the patient on D2, D7 and D15 after discharge. The coordinating nurse phones the patient on D7 to review the symptoms reported, assess compliance with treatment and provide support. In the event of grade ≥ 2 symptoms, the nurse contacts th

Primary outcome measures

• Compliance with ePRO monitoring [Time frame: Day 2]
• Compliance with the telephone call at day 7 [Time frame: Day 7]
• Patient satisfaction with the care pathway [Time frame: Day 15]

Secondary outcome measures (7)

• Quality of the transition pathway to home [Time frame: Day 15]
• Quality of life as reported by the patient [Time frame: Day 0]
• Quality of life as reported by the patient [Time frame: Day 7]
• Quality of life as reported by the patient [Time frame: Day 15]
• Quality of life as reported by the patient [Time frame: Day 30]
• Patient satisfaction with their care [Time frame: Day 15]
• Rate of readmissions to a healthcare facility [Time frame: One month after hospitalization]

Eligibility criteria

Inclusion criteria

• The patient must have given their free and informed consent and signed the consent form
• The patient must be a member or beneficiary of a health insurance plan
• Adult patient hospitalized in an oncology unit for at least 48 hours.
• Patient capable of using a connected device, in possession of a smartphone or tablet, and with an internet connection at home.
• Patient discharged from hospital to go home.

Exclusion criteria

• The patient is in a period of exclusion determined by a previous study
• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• Patient considered to be at the end of life.
• Patient unable to read and understand French
• Patient discharged from hospitalization to a home care facility
• Patient having been hospitalized in a full-time inpatient setting for a scheduled procedure (chemotherapy or interventional procedure)
• Pregnant, parturient, or breastfeeding

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model

Cohort

Study locations

France · 1 center

• Centre Hospitalier de Nimes — Nîmes

Identifiers

NCT: NCT07256444 · NIMAO/2023-2/AB01

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗